The invention relates to a stent for positioning in a body conduit or to a method for producing this stent, with the stent containing a contrast means for x-radiation.
A stent is a tubular implant which provides radial outwards support for the wall of a body conduit, e.g. a blood vessel, bile duct, an air conduit or an esophagus. The stent usually consists of the elastic material, e.g. a metal or metal alloy or a polymer, and frequently has a mesh or network or spiral-type structure, with stents in the form of a metal mesh being the most widely used. The stent is introduced into the relevant body conduit with the aid of a catheter and is bought into adhesive contact there with the wall of the body conduit. With blood vessels specifically stents are introduced into the wall of the vessel as endoluminal vessel prostheses for therapy of stenoses caused by arterosclerotic plaque.
A stent is known from US 2004/0148014 A1 in which markers are impermeable to x-rays are distributed, in order to make the position of the stent clearly visible on an x-ray image when it has been used in the relevant body conduit. These markers most contain substances such as heavy metals or iodine compounds which, when used in the body conduit—even with an appropriate encapsulation—present a potential danger to health.
The object of the present invention is to specify a stent which is simple to produce, which, despite being easily visible on an x-ray image, still exhibits good biological compatibility without a potential danger to health.
This object is achieved by a stent or by a method in accordance with the independent claims. Advantageous embodiments of the invention are the subject of the assigned dependent claims in each case.
Through the inventive contrast means contained in the stent, which has a greater permeability for x-radiation than body tissue surrounding the stent in the relevant body conduit, the introduction of a potentially hazardous contrast means with a lower permeability for x-radiation in the body conduit is avoided and yet easy identification of the stent introduced into the relevant body conduit on an x-ray image of the body conduit is still guaranteed.
Contrast means with a higher permeability for x-radiation than the surrounding body tissue in each case are known as negative contrast means. They are shown as dark areas on an x-ray image. On the other hand contrast means with a lower permeability for x-radiation than the surrounding body tissue it are referred to as positive contrast means. They are shown as light areas on the x-ray image. Unlike positive contrast means which, as a result of the compounds that they contain with elements with a high atomic number, are at least potentially damaging to health, negative contrast means mostly have good biological compatibility.
A negative contrast means in the form of a gas, especially in the form of carbon dioxide, enables an especially high permeability for x-radiation and thus an especially good detectability of the position of the stent in the body conduit on the X-ray image. As a rule gases exhibit a far lower atomic density than a solid or a liquid with the same substance so that gases of the low atomic density are accordingly particularly permeable for x-radiation. In addition, gases, especially carbon dioxide, are inexpensive by comparison with the usual positive contrast means.
By enclosing the gas in cavities of the stent on the one band the stability of the stent is increased and on the other hand by selecting an appropriate distribution density of the cavities or through the form of the hollow cavities the elastic properties of the stent can be adapted to the relevant purpose for which it is used or to the relevant body conduit. Tubular cavities extending in the longitudinal direction of the stent for example allow the stent to be bent easily in the longitudinal direction without this process reducing the radial stability of the stent. In addition, the stent is then also still able to be detected on the x-ray image if for example a few cavities are not gas-tight and some of the gas escapes when the stent is positioned, during its expansion or during its time in the body conduit. In addition, a stent with cavities containing the gas is simple and cheap to produce.
A stent consisting at least partly of a polymer guarantees especially good biocompatible properties and a low-cost production of the stent. The stent can for example consist entirely of the polymer or be coated with the polymer. A stent made entirely of polymer, such as silicone or rubber for example, where necessary except for the negative contrast means, is, in addition, especially elastic and can also be easily adapted to a distortion of the body conduit.
In accordance with one embodiment of invention, the polymer is embodied in the form of a polymer foam containing the cavities. A stent consisting of this polymer foam is especially simple to produce by foaming up the polymer with the gas. Polyurethane is suitable for example as the polymer and can be foamed up in a manner known per-se with little effort. The still liquid polymer can be foamed up in the production of the stent both by introducing the gas into it and by letting a gas dissolved in the polymer escape.
In accordance with a further embodiment of the invention, the polymer is embodied in the form of small polymer balls containing the cavities. These can be incorporated into the stent particularly easily, e.g. by mixing the polymer balls with a liquid material from which the stent is formed, in which case the liquid material itself can again also be a polymer.
The inventive method of production for the stent consisting at least partly of the polymer provides a simple means of producing the stent which is clearly visible on the x-ray image and yet is still biologically compatible. The stent is simultaneously positioned in the body conduit using a catheter positioned in the body conduit. The stent has a filling area at least partly enclosing this catheter which can be filled with a polymer mass to be hardened into the stent. In addition, the stent is precisely adapted to the form of the relevant body conduit by its being formed in the body conduit so that the stent is secured against slippage in the body conduit and damage to the body conduit by the stent is avoided.
In accordance with an embodiment of the invention there is advantageous provision for filling the filling area positioned at the position intended for the stent with a polymer mass temporally accommodated in an inner chamber of the catheter. In this way, especially for simple introduction of the catheter into the body conduit, it is possible to fill the filling area with the plastic mass only when the position intended for the stent is reached.
The invention, as well as further advantageous embodiments of the invention in accordance with features of the dependent claims, are explained in greater detail below with reference to schematic diagrams of exemplary embodiments in the drawing, without this restricting the invention to this exemplary embodiment in any way. The Figures show:
There is provision to feed a catheter through an opening 5 passing through the stent 1, 2 and to place the stent 1, 2 on the catheter in such a way that the stent encloses an expandable balloon section of the catheter in the form of a tube. Subsequently the stent 1, 2 is introduced with the aid of the catheter into a body conduit and is adapted there to the internal diameter of the body conduit by an expansion of the balloon section. Finally the catheter is removed while the stent 1, 2 remains in the body conduit and provides radial support for this.
The gas contained in the cavities, e.g. carbon dioxide, operates as a negative contrast means so that the position of the stent 1, 2 within the body conduit can be detected on an x-ray image of the body conduit. The more gas that is enclosed in the ratio by volume to the remaining stent material in the stent 1, 2 the clearer the image of the stent 1, 2 that stands out as a dark area against the image of the body tissue surrounding the stent 1, 2.
The stent, after its expansion into its expanded form, retains this form even after the catheter has been removed. The stent consists at least partly of a plastic deformable material which permanently assumes its changed shape through a radial expansion. This material can for example be embodied in the form of a number of rings distributed over the length of the stent 1, 2 and surrounding the opening 5 in each case. Alternatively it is also possible to arrange an elastically deformable wire mesh within the stent 1, 2 which keeps the stent 1, 2 in the expanded state after its expansion.
Instead of a surface enclosed in a radial direction, the stent 1, 2 can also have a surface in the form of a mesh or in the form of a grid.
In an especially uncomplicated manner the polymer mass 13 is mixed with the negative contrast means before the filling area 9 is filled with this polymer mass 13. This removes the need for separate filling of the filling area 9 with the polymer mass 13 and with the negative contrast means 6. In this exemplary embodiment the negative contrast means in the form of the small polymer balls 6 filled with carbon-dioxide is mixed in homogeneously with the polymer mass 13 before the catheter 8 is introduced into the body conduit 7.
Depending on the contrast means used in each case it is also possible to have the filling area 9 filled with the negative contrast means before it is filled with the polymer mass 13.
When a contrast means in the form of a gas, especially in the form of carbon dioxide is used, this is distributed especially easily and cost-effectively by foaming up the polymer mass with the gas in the stent 8. The foaming-up of the gas can be undertaken both before and also after the filling of the filling area with the polymer mass 13. In the case of letting the gas escaping into the polymer, this process is expediently undertaken in the filling area 9.
After the filling openings 11 or 12 have been closed again the polymer mass 13 is hardened to create the stent 20, depending on the polymer simply after a hardening period.
To adapt the stent 20 in respect of its internal diameter an inflatable balloon section surrounded by the filling area (9) is additionally provided which is inflated after the positioning of the filling area 9 at the position intended for the stent 20.
By mixing the negative contrast means into the polymer mass 13 the stent 20 produced from this polymer mass 13 is easy to be detected on an x-ray image of the body conduit 7.
In an advantageous manner a means for liquefying or for hardening of the polymer mass 13 by a change of temperature is provided. This enables the polymer mass 13, because of its good deformability in the liquid state, to be particularly well adapted to the properties of the body conduit 7 and enables the filling area 9 to be filled especially simply. It is possible to arrange a heating element in the catheter 8 for liquefying or hardening of the polymer mass 13 by heating it up.
To enable stents of different lengths to be produced with the same catheter, further clamping rings can be provided between the clamping rings 15 or 16. The envelope 10 is accordingly held with one of its ends by clamping ring 16 and with its other end by one of the other clamping rings.
The invention can be summarized as follows: Through a contrast means contained in an inventive stent which exhibits a higher permeability for x-radiation than body tissue surrounding the stent in a relevant body conduit, this stent can be clearly detected in its position on the x-ray image of the relevant body conduit and at the same time has good biological compatibility. A gas contained in a cavities of the stent is in particular provided as the contrast means. The inventive production method for this stent with the aid of a catheter embodied especially for the purpose enables the production of the stent from a malleable polymer mass in the relevant body conduit so that the stent is adapted especially precisely to the shape of the relevant body conduit.
Number | Date | Country | Kind |
---|---|---|---|
10 2005 024 625 | May 2005 | DE | national |
This is a divisional application of U.S. patent application Ser. No. 11/442,887, filed May 30, 2006, now abandoned which claims priority of German application No. 10 2005 024 625.7 filed May 30, 2005. Both applications are incorporated by reference herein in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
5092841 | Spears | Mar 1992 | A |
5344444 | Glastra | Sep 1994 | A |
5575815 | Slepian et al. | Nov 1996 | A |
5725568 | Hastings | Mar 1998 | A |
5749922 | Slepian et al. | May 1998 | A |
5785679 | Abolfathi et al. | Jul 1998 | A |
5899917 | Edwards et al. | May 1999 | A |
6176871 | Pathak et al. | Jan 2001 | B1 |
6482179 | Chu et al. | Nov 2002 | B1 |
6569190 | Whalen et al. | May 2003 | B2 |
6689148 | Sawhney et al. | Feb 2004 | B2 |
7083643 | Whalen et al. | Aug 2006 | B2 |
7156872 | Strecker | Jan 2007 | B2 |
20030134032 | Chaouk et al. | Jul 2003 | A1 |
20040093069 | Priewe et al. | May 2004 | A1 |
20040093074 | Hildebrand et al. | May 2004 | A1 |
20040148014 | Nuutinen et al. | Jul 2004 | A1 |
20040236410 | Herweck et al. | Nov 2004 | A1 |
20050004584 | Franco et al. | Jan 2005 | A1 |
20100331947 | Shalev et al. | Dec 2010 | A1 |
Number | Date | Country |
---|---|---|
692 02 308 | Jan 1993 | DE |
201 19 322 | Mar 2002 | DE |
1 464 300 | Oct 2004 | EP |
WO 9424962 | Nov 1994 | WO |
Entry |
---|
“Quality . . . Measured in Outcomes”; IOMED GmbH; [retrieved from Internet on] Jun. 13, 2006; [retrieved from Internet at] http://www.iomed.com, p. 1. |
“Marker Band Swaging Equipment Uses Flexures to Guide Motion”; ThomasNet, IndustrialNews Room; Oct. 23, 2002; [retrieved from Internet on] Jun. 9, 2006; [retrieved from Internet at] http://industrialnewsroom.com/fullstory/15429, pp. 1-4. |
Number | Date | Country | |
---|---|---|---|
20090062902 A1 | Mar 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11442887 | May 2006 | US |
Child | 12231666 | US |